Judge Rules in Favor of Defense in Zimmer Biomet Defective NexGen Flex Knee Replacement Bellwether Lawsuit
Last month, Zimmer Biomet, a company that manufactures medical devices, won a lawsuit against a plaintiff who alleged that he suffered serious injuries as a result of being implanted with Zimmer Biomet’s NexGen Flex knee replacement device. The federal judge presiding over the Illinois lawsuit declared that the plaintiff had failed to establish that the product suffered from a design defect.
In 2007, the U.S. Food and Drug Administration, which is responsible for regulating medical devices, among other things, approved the NexGen Flex device. It is designed to offer greater flexibility than other devices designed for knee replacement.
Since then, thousands of lawsuits have been filed against the manufacturer, alleging that the device is unreasonably dangerous because it cannot withstand the force of extra flexion. The company, which is based in Warsaw, Indiana, denied that the device is unable to withstand this extra flexion in marketing materials associated with the device. Other plaintiffs have alleged that the device is susceptible to premature weakening because of a design flaw, leading to multiple revision surgeries to correct the errors.